7.79
price up icon1.76%   0.11
 
loading
10 X Genomics Inc stock is traded at $7.79, with a volume of 480.44K. It is up +1.76% in the last 24 hours and down -24.78% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$7.68
Open:
$7.86
24h Volume:
480.44K
Relative Volume:
0.16
Market Cap:
$1.02B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-3.8564
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-4.23%
1M Performance:
-24.78%
6M Performance:
-48.38%
1Y Performance:
-71.89%
1-Day Range:
Value
$7.74
$8.01
1-Week Range:
Value
$7.25
$8.22
52-Week Range:
Value
$6.78
$29.37

10 X Genomics Inc Stock (TXG) Company Profile

Name
Name
10 X Genomics Inc
Name
Phone
(925) 401-7300
Name
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Employee
1,306
Name
Twitter
@10xgenomics
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
TXG's Discussions on Twitter

Compare TXG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
TXG
10 X Genomics Inc
7.79 1.02B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
212.37 36.39B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
51.81 9.87B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
43.78 7.46B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
82.45 7.21B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
35.40 6.30B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-13-25 Downgrade Leerink Partners Outperform → Market Perform
Sep-03-24 Initiated Leerink Partners Outperform
Jul-22-24 Upgrade Jefferies Hold → Buy
Jul-18-24 Downgrade JP Morgan Overweight → Neutral
Jul-10-24 Downgrade Deutsche Bank Buy → Hold
Jun-27-24 Downgrade Wolfe Research Outperform → Peer Perform
Jun-25-24 Downgrade Guggenheim Buy → Neutral
Jun-03-24 Resumed Jefferies Hold
May-01-24 Downgrade TD Cowen Buy → Hold
Dec-14-23 Initiated Guggenheim Buy
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Upgrade BofA Securities Underperform → Neutral
Jul-05-23 Resumed JP Morgan Overweight
May-10-23 Initiated Barclays Overweight
Mar-31-23 Initiated Stephens Overweight
Feb-02-23 Initiated UBS Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Aug-18-22 Downgrade Goldman Neutral → Sell
Jul-25-22 Initiated Canaccord Genuity Buy
Jul-15-22 Downgrade BofA Securities Neutral → Underperform
Jul-15-22 Downgrade William Blair Outperform → Mkt Perform
Oct-15-21 Resumed Cowen Outperform
Sep-14-21 Downgrade BofA Securities Buy → Neutral
Mar-15-21 Initiated William Blair Outperform
Dec-02-20 Initiated Goldman Neutral
Sep-09-20 Initiated Morgan Stanley Overweight
Jul-10-20 Initiated Stifel Buy
Mar-05-20 Initiated Guggenheim Buy
Jan-07-20 Initiated Citigroup Buy
Oct-07-19 Initiated BofA/Merrill Buy
Oct-07-19 Initiated Cowen Outperform
Oct-07-19 Initiated JP Morgan Overweight
Sep-24-19 Initiated Evercore ISI Outperform
View All

10 X Genomics Inc Stock (TXG) Latest News

pulisher
Apr 19, 2025

Advancing the Future of Biomarker-Driven Immunotherapy - Fierce Biotech

Apr 19, 2025
pulisher
Apr 18, 2025

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis (PR Newswire) - Aktiellt

Apr 18, 2025
pulisher
Apr 15, 2025

10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025 - BioSpace

Apr 15, 2025
pulisher
Apr 14, 2025

BofA Securities Cuts Price Target on 10x Genomics to $12 From $16, Neutral Rating Maintained - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

10x Genomics (TXG) Price Target Reduced Amid Policy and Economic Concerns | TXG Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Biotech Leader 10x Genomics Announces Q1 2025 Earnings Date: What to Watch - Stock Titan

Apr 14, 2025
pulisher
Apr 11, 2025

Positive Sentiment Still Eludes 10x Genomics, Inc. (NASDAQ:TXG) Following 29% Share Price Slump - simplywall.st

Apr 11, 2025
pulisher
Apr 11, 2025

Spatial Genomics Transcriptomics Market Is Booming Worldwide | - openPR.com

Apr 11, 2025
pulisher
Apr 10, 2025

Single-cell Omics Emerging Technologies and Markets Report - GlobeNewswire

Apr 10, 2025
pulisher
Apr 10, 2025

Single-cell Omics Emerging Technologies and Markets Report 2025: 10x Genomics, Thermo Fisher & Illumina Lead $9.1 Billion Single-cell Omics Market by 2029 - Yahoo Finance

Apr 10, 2025
pulisher
Apr 09, 2025

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know - Yahoo Finance

Apr 09, 2025
pulisher
Apr 05, 2025

10x Genomics Reports Third Quarter 2023 Financial Results - Seeking Alpha

Apr 05, 2025
pulisher
Apr 05, 2025

10X Genomics stock hits 52-week low at $7.43 amid market challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

10X Genomics stock hits 52-week low at $7.43 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 01, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Apr 01, 2025
pulisher
Mar 28, 2025

10X Genomics stock plunges to 52-week low of $9.27 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

10X Genomics stock plunges to 52-week low of $9.27 - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

We Think 10x Genomics (NASDAQ:TXG) Can Easily Afford To Drive Business Growth - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

UPC infringement case can resume after EPO upholds 10x Genomics patent - JUVE Patent

Mar 27, 2025
pulisher
Mar 21, 2025

10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus.com

Mar 21, 2025
pulisher
Mar 20, 2025

10x Genomics: Lower Cost Innovation May Drive A Rebound - Seeking Alpha

Mar 20, 2025
pulisher
Mar 18, 2025

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

Mar 18, 2025
pulisher
Mar 11, 2025

Long Read Sequencing Market Top Companies Study10X Genomics, - openPR

Mar 11, 2025
pulisher
Mar 11, 2025

2 Reasons to Sell TXG and 1 Stock to Buy Instead - Yahoo Finance

Mar 11, 2025
pulisher
Mar 10, 2025

Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex

Mar 10, 2025
pulisher
Mar 09, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

10x Genomics IncOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

10x Genomics’ (TXG) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Citigroup Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Strategic Move: Healthcare Giant Zimmer Biomet Taps Communications Veteran from 10x Genomics - Stock Titan

Mar 06, 2025
pulisher
Mar 05, 2025

10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

10x Genomics Dodges Appeal In DNA Analysis Patent Clash - Law 360 UK

Mar 05, 2025
pulisher
Mar 05, 2025

10x genomics CEO Serge Saxonov sells $84,393 in stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Sells 1,641 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

10x genomics CEO Serge Saxonov sells $84,393 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Sanctuary Advisors LLC Purchases 6,474 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Short Interest in 10x Genomics, Inc. (NASDAQ:TXG) Expands By 34.4% - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Plann - GuruFocus.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences’ Planned ATAC Products - The Malaysian Reserve

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics secures injunction against Parse Biosciences - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics gets injunction against Parse Biosciences' ATAC Products (TXG:NASDAQ) - Seeking Alpha

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products – Company Announcement - Financial Times

Mar 03, 2025
pulisher
Mar 02, 2025

10 Promising Biotech Stocks to Invest in (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

ARK Investment Management LLC Purchases 1,193,712 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

SVB Wealth LLC Acquires Shares of 522,609 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Ieq Capital LLC Purchases 50,722 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ING Groep NV Acquires New Shares in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

10x Genomics, Inc. (NASDAQ:TXG) CEO Sells $56,368.44 in Stock - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Director of 10x Genomics Picks Up 184% More Stock - Simply Wall St

Feb 27, 2025
pulisher
Feb 27, 2025

Oxford Nanopore Expands Compatibility With 10x Genomics To Unlock Deeper Insights in Single-Cell Transcriptomics - Technology Networks

Feb 27, 2025

10 X Genomics Inc Stock (TXG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

10 X Genomics Inc Stock (TXG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Saxonov Serge
Chief Executive Officer
Feb 28 '25
Sale
10.63
7,942
84,393
871,540
$19.50
price up icon 0.70%
$26.23
price up icon 1.18%
$14.34
price down icon 0.41%
$23.10
price up icon 1.56%
$15.85
price up icon 0.64%
health_information_services WAY
$35.05
price up icon 0.14%
Cap:     |  Volume (24h):